Morse Asset Management’s CareDx CDNA Stock Holding History

Morse Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-800	Closed	-$15.6K	–	380
2025 Q2	$15.6K	Sell	800 -5,000	-86%	-$88.8K	﹤0.01%	241
2025 Q1	$103K	Buy	+5,800	New	+$125K	0.03%	172

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morse Asset Management's CDNA Position: Q3 2025 in Review

Morse Asset Management sold out of CareDx (CDNA) in Q3 2025, closing a stake of 800 shares — an estimated $15.6K sold.

Morse Asset Management first reported a position in CDNA in Q1 2025 and held it in 2 quarters. The position peaked at $103K in Q1 2025. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

Morse Asset Management reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
Morse Asset Management sold 800 CareDx shares in Q3 2025, an estimated $15.6K.
Morse Asset Management first reported a position in CareDx in Q1 2025 and held it in 2 quarters.
Morse Asset Management's CareDx position peaked at $103K in Q1 2025.
187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Morse Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.